Sylvia M. Brakenhoff

Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)

Grishma Hirode, Hannah Choi, Chien‐Hung Chen et al. · Gastroenterology · 2021 · 187 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels

Milan J. Sonneveld, Shao‐Ming Chiu, Jun Yong Park et al. · Journal of Hepatology · 2022 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study)

Grishma Hirode, Bettina E. Hansen, Chien‐Hung Chen et al. · The American Journal of Gastroenterology · 2023 · 37 citations · Full text

Pharmacy, Pharmacotherapy, Hepatic Pharmacotherapy +16

Predictors of hepatic flares after nucleos(t)ide analogue cessation – Results of a global cohort study (RETRACT-B study)

Edo J. Dongelmans, Grishma Hirode, Bettina E. Hansen et al. · Journal of Hepatology · 2024 · 27 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Hepatitis B virus RNA decline without concomitant viral antigen decrease is associated with a low probability of sustained response and hepatitis B surface antigen loss

Sylvia M. Brakenhoff, Robert A. de Man, André Boonstra et al. · Alimentary Pharmacology & Therapeutics · 2020 · 25 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17